These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 118835)

  • 21. [Report of the 3d International Conference on the immunology of meningococcal meningitis. Current status of meningococcus B vaccine].
    Del Real G
    Rev Sanid Hig Publica (Madr); 1979; 53(11-12):1639-49. PubMed ID: 45419
    [No Abstract]   [Full Text] [Related]  

  • 22. Measurement of growth-inhibiting (bactericidal) antibodies in patients with meningococcal meningitis and in subjects immunized with meningococcal polysaccharide vaccine by a [3H]thymidine assay.
    Hassan-King M; Greenwood BM; Whittle HC
    J Clin Microbiol; 1985 Jul; 22(1):136-8. PubMed ID: 3926814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningococcal vaccines in prevention and control of meningitis.
    Saxena SN; Rawal IJ; Tripathi KK; Gupta P
    Indian Pediatr; 1985 Jun; 22(6):453-65. PubMed ID: 3938978
    [No Abstract]   [Full Text] [Related]  

  • 24. Susceptibility to meningococcal meningitis.
    Sabath LD; Rosner B
    N Engl J Med; 1973 May; 288(22):1185. PubMed ID: 4633552
    [No Abstract]   [Full Text] [Related]  

  • 25. [Status of cellular immunity in viral, serous and meningococcal meningitis].
    Zaplotnaia AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):39-41. PubMed ID: 1326171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meningococci.
    Sippel JE
    Crit Rev Microbiol; 1981; 8(3):267-302. PubMed ID: 6781818
    [No Abstract]   [Full Text] [Related]  

  • 27. Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response.
    Herva E; Leinonen M; Käyhty H; Mäkelä PH; Vetoniemi-Korhonen SL
    J Infect; 1983 Jan; 6(1):55-60. PubMed ID: 6411822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. II. Immune specificity of antimeningococcal activity.
    Smith LF; Lowell GH
    J Infect Dis; 1980 Jun; 141(6):748-51. PubMed ID: 6771337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children.
    Käyhty H; Karanko V; Peltola H; Sarna S; Mäkelä PH
    J Infect Dis; 1980 Dec; 142(6):861-8. PubMed ID: 6780634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immune response to anti-meningococcal vaccines].
    Milagres LG; Melles CE
    Rev Saude Publica; 1993 Jun; 27(3):221-6. PubMed ID: 8115838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for familial immune defect in meningococcal meningitis.
    Whittle HC; Oduloju A; Evans-Jones G; Greenwood BM
    Br Med J; 1976 May; 1(6020):1247-50. PubMed ID: 817771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship of eicosanoids to cellular and humoral immunity factors in meningococcal infection].
    Pokrovskiĭ VI; Rezhabek AE
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jan; (1):63-8. PubMed ID: 2496543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of dose to the reactogenicity and immunogenicity of meningococcal polysaccharide vaccines in adults.
    Griffiss JM; Brandt BL; Broud DD; Altieri PL; Berman SL
    Mil Med; 1985 Oct; 150(10):529-33. PubMed ID: 3934585
    [No Abstract]   [Full Text] [Related]  

  • 34. Crossed immunoelectrophoretic analysis of Neisseria meningitidis antigens and of corresponding antibodies in patients with meningococcal disease.
    Hoff GE; Høiby N
    Acta Pathol Microbiol Scand C; 1978 Feb; 86(1):1-9. PubMed ID: 81590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cross-reacting intraspecies antigens of Neisseria meningitidis. II. The dynamics of antimeningococcal antibodies to cross-reacting antigens in different forms of meningococcal infection].
    Martynov IuV; Gracheva AM; Samsonova IM; Mol'kova LSh; Petina GK
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):60-5. PubMed ID: 6084377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Level of rosette-forming cells in patients with meningococcal infections].
    Krasnoproshina LI; Bolibrukh TA; Pokrovskiĭ VI; Matveeva SM; Semina NA
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jan; (1):56-60. PubMed ID: 6785946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An in vitro model to study the effect of antibodies and cell receptor analogues on meningococcal adherence to human oroepithelial cells.
    Carbonare SB; Nuñez-Vaca SP; Bajerl P; Honorio AC; Silva ML; Carneiro-Sampaio MM
    Braz J Med Biol Res; 1996 Feb; 29(2):239-44. PubMed ID: 8731355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meningococcal molecular mimicry and the search for an ideal vaccine.
    Griffiss JM; Yamasaki R; Estabrook M; Kim JJ
    Trans R Soc Trop Med Hyg; 1991; 85 Suppl 1():32-6. PubMed ID: 1725072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nature of the antigen present in the cerebrospinal fluid and serum of patients with group A meningococcal meningitis.
    Greenwood BM; Whittle HC
    Clin Exp Immunol; 1974 Mar; 16(3):413-7. PubMed ID: 4219838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of the sensitivity and specificity of dried and liquid meningococcal erythrocyte diagnostic agents A, C and Y in a controlled trial].
    Nikitiuk NM; Sumarokov AA; Nefedova LA; Pavlova LI; Kostiukova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):72-6. PubMed ID: 6435359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.